Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HIND NASDAQ:OSRH OTCMKTS:UEEC OTCMKTS:USAQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHINDVyome$2.17$2.18$1.75▼$18.60$15.23M1.4821,255 shs26,366 shsOSRHOSR$0.39$0.52$0.37▼$1.79$13.75M0.611.02 million shs791,439 shsUEECUnited Health Products$0.06$0.06$0.04▼$0.13$15.67M-0.29130,048 shs83,412 shsUSAQQHSLab$0.34$0.52$0.08▼$1.14$3.83M0.482,229 shs1,700 shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHINDVyome0.00%-5.65%+2.84%-4.82%+216,999,900.00%OSRHOSR0.00%+2.83%-21.64%-10.34%-75.81%UEECUnited Health Products0.00%+6.95%+10.09%+6.01%-50.50%USAQQHSLab0.00%+32.94%-34.81%-49.85%+60.13%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHINDVyome$2.17$2.18$1.75▼$18.60$15.23M1.4821,255 shs26,366 shsOSRHOSR$0.39$0.52$0.37▼$1.79$13.75M0.611.02 million shs791,439 shsUEECUnited Health Products$0.06$0.06$0.04▼$0.13$15.67M-0.29130,048 shs83,412 shsUSAQQHSLab$0.34$0.52$0.08▼$1.14$3.83M0.482,229 shs1,700 shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHINDVyome0.00%-5.65%+2.84%-4.82%+216,999,900.00%OSRHOSR0.00%+2.83%-21.64%-10.34%-75.81%UEECUnited Health Products0.00%+6.95%+10.09%+6.01%-50.50%USAQQHSLab0.00%+32.94%-34.81%-49.85%+60.13%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHINDVyome 2.40Hold$15.00591.24% UpsideOSRHOSR 1.00SellN/AN/AUEECUnited Health Products 0.00N/AN/AN/AUSAQQHSLab 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest USAQ, HIND, UEEC, and OSRH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026HINDVyome Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/4/2026HINDVyome Litchfield Hills ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy5/1/2026HINDVyome Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)3/27/2026OSRHOSR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 6/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHINDVyome$320K47.60N/AN/A$0.67 per share3.24OSRHOSR$2.91M4.73N/AN/A$4.95 per share0.08UEECUnited Health ProductsN/AN/AN/AN/A($0.01) per shareN/AUSAQQHSLab$2.69M1.42N/AN/A$0.14 per share2.42Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHINDVyome-$10.26M-$12.27N/AN/AN/A-270.58%-203.92%-134.16%N/AOSRHOSR-$27.06M-$0.33N/AN/AN/A-363.26%-7.24%-5.41%N/AUEECUnited Health Products-$2.67MN/AN/AN/AN/AN/AN/A-783.98%N/AUSAQQHSLab$460K$0.0311.30N/AN/A15.60%-27.74%-6.98%8/19/2026 (Estimated)Latest USAQ, HIND, UEEC, and OSRH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026OSRHOSRN/A-$0.09N/A-$0.0880N/A$0.48 million5/12/2026Q1 2026HINDVyomeN/A-$0.15N/A-$0.15N/A$0.03 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHINDVyomeN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/AUEECUnited Health ProductsN/AN/AN/AN/AN/AUSAQQHSLabN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHINDVyomeN/A4.274.27OSRHOSRN/A0.160.14UEECUnited Health ProductsN/A0.010.01USAQQHSLabN/A1.681.61Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHINDVyome22.06%OSRHOSR55.30%UEECUnited Health Products0.07%USAQQHSLabN/AInsider OwnershipCompanyInsider OwnershipHINDVyome33.00%OSRHOSR36.80%UEECUnited Health Products1.50%USAQQHSLab74.19%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHINDVyome507.02 million4.70 millionN/AOSRHOSRN/A35.10 million22.19 millionN/AUEECUnited Health Products4261.19 million257.27 millionNot OptionableUSAQQHSLab511.28 million2.91 millionNot OptionableUSAQ, HIND, UEEC, and OSRH HeadlinesRecent News About These CompaniesQHSLab Highlights Investor Outreach at Planet MicroCap ConferenceJune 17 at 1:31 PM | tipranks.comQHSLab (OTCQB:USAQ) Reports 127% Year-Over-Year ISP Growth and Launches Q-Connect GLP-1 Support AssessmentApril 21, 2026 | globenewswire.comQHSLab Inc.April 1, 2026 | barrons.comQHSLab (OTCQB:USAQ) Reports Strong Fiscal 2025 Results with Revenue Growth, Expanding Margins, and Significant Balance Sheet ImprovementMarch 31, 2026 | globenewswire.comQhslab's Strategic Pivot: Harnessing AI Diagnostics for GrowthMarch 7, 2026 | aktiencheck.deAQHSLab, Inc.: QHSLab (OTCQB:USAQ) Reports Preliminary Unaudited 2025 Financial Results With Strong Revenue Growth, Expanding Margins, and Significant Debt ReductionJanuary 26, 2026 | finanznachrichten.deQHSLab (OTCQB:USAQ) Reports Preliminary Unaudited 2025 Financial Results With Strong Revenue Growth, Expanding Margins, and Significant Debt ReductionJanuary 26, 2026 | globenewswire.comQHSLab Simplifies Capital Structure With Debt-for-Equity DealJanuary 23, 2026 | tipranks.comQHSLab (OTCQB:USAQ) Initiates Board Expansion Process to Strengthen Governance and Support Next Phase of GrowthJanuary 16, 2026 | globenewswire.comQHSLab, Inc.: QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor SessionJanuary 7, 2026 | finanznachrichten.deQHSLab reports strong 2025 growth and deleveraged balance sheetJanuary 6, 2026 | msn.comQHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor SessionJanuary 6, 2026 | globenewswire.comQHSLab Modifies Debt and Converts Note to EquityJanuary 2, 2026 | tipranks.comQHSLab strengthens balance sheet with new equity financingDecember 29, 2025 | msn.comQHSLab, Inc. (OTCQB:USAQ) Completes $500K Private Placement, Enters 2026 With Clean Capital StructureDecember 29, 2025 | globenewswire.comQHSLab (OTCQB:USAQ) Announces Launch of Q-Cog™ to Support Early Detection of Mild Cognitive Impairment and DementiaDecember 3, 2025 | globenewswire.comQHSLab Releases December 2025 Corporate PresentationDecember 1, 2025 | tipranks.comOther news to note for Nov. 20, 2025November 21, 2025 | bioworld.comBQHSLab Retires Convertible Debt, Strengthens Financial PositionNovember 18, 2025 | tipranks.comQHSLab (OTCQB:USAQ) Completes Repurchase of Legacy Debt, Enhancing Capital Structure, Strengthening Balance Sheet and Reducing Future DilutionNovember 18, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 2026Coke's $10B India IPO Plan Pops the Top on Hidden ValueBy Jeffrey Neal Johnson | June 3, 2026Investors Abandoned These 3 AI Stocks Too Early, Says Jeff ClarkBy Bridget Bennett | May 21, 2026What's Behind the Social Media Controversy Surrounding IonQ?By Nathan Reiff | June 15, 2026USAQ, HIND, UEEC, and OSRH Company DescriptionsVyome NASDAQ:HIND$2.17 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$2.23 +0.06 (+2.72%) As of 06/18/2026 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.OSR NASDAQ:OSRH$0.39 0.00 (0.00%) Closing price 06/18/2026 04:00 PM EasternExtended Trading$0.38 -0.01 (-1.99%) As of 06/18/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.United Health Products OTCMKTS:UEEC$0.06 0.00 (0.00%) As of 06/18/2026 03:39 PM EasternUnited Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.QHSLab OTCMKTS:USAQ$0.34 0.00 (0.00%) As of 06/18/2026 11:10 AM EasternQHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate VMware: Broadcom's Second Biggest Business Set to Accelerate American Eagle’s Q1 Beat Leaves Investors With a Bigger Question Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
